Firms

Zynext Ventures

Zynext Ventures

Pennington, New Jersey, United States

zynextventures.comin.linkedin.comx.com

Zynext Ventures is the corporate venture investment arm of Zydus Lifesciences, based in Pennington, New Jersey. It invests in seed, early-stage and growth-stage healthcare companies, including preclinical and clinical therapeutics, medical devices, imaging and digital technologies. Its published approach uses data analytics and AI to evaluate opportunities and offers access to Zydus’s pharmaceutical, regulatory and commercial capabilities. Published portfolio investments include neuro42, developing portable MRI and robotics for neurological imaging and interventions; Promaxo, developing low-field MRI and minimally invasive robotics; Feldan Therapeutics, developing intracellular drug delivery; Illexcor Therapeutics, developing oral sickle cell therapies; and Agenus, developing cancer immunotherapies. SEC filings identify Zynext Ventures USA LLC as a Delaware investment vehicle wholly owned by Singapore’s Zynext Ventures Pte Ltd, which is wholly owned by Zydus Lifesciences. These legal vehicles are represented under one venture-arm identity; neither the parent’s market capitalization nor individual portfolio investments constitute a disclosed raised venture fund.

Founded
—
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Jay KothariJay KothariDirector
Mitesh ShahMitesh ShahPrincipal
Vishwa TrivediVishwa TrivediSenior Associate

Co-investing

No co-investors on record yet.

Investments